Literature DB >> 6403881

Comprehensive study of haemostasis in nephrotic syndrome.

F Panicucci, A Sagripanti, M Vispi, E Pinori, L Lecchini, G Barsotti, S Giovannetti.   

Abstract

A comprehensive study of haemostasis has been performed in a homogeneous group of 20 patients with nephrotic syndrome without renal failure. We have found unchanged number of platelets and a significant increase of platelet adhesiveness and aggregation; increased levels of activity and related antigen of fibrinogen, of factor VIII, of activity of factors II, VII and X and of antigens of factors XIII. Antithrombin III was unchanged in plasma and was detected in the urine. Euglobulin lysis times were decreased, and levels of plasminogen and its activators were increased after a venous occlusion test. At the same time urokinase inhibitors and antiplasmins were increased not only after, but also before a venous occlusion test. Fibrinogen degradation products have been found in the urine of all our patients but not in their sera.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6403881     DOI: 10.1159/000182895

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  10 in total

1.  Protein C and anti-thrombin III levels in nephrotic syndrome and amyloidosis.

Authors:  R Topaloğlu; U Saatçi; A Bakkaloğlu; N Beşbaş; Y Başsoy
Journal:  Pediatr Nephrol       Date:  1992-01       Impact factor: 3.714

Review 2.  Do circulating factors play a role in the pathogenesis of minimal change nephrotic syndrome?

Authors:  W W Bakker; W H van Luijk
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

3.  Upper limb venous thrombosis complicating amyloidosis.

Authors:  W Dickey; M E Callender; E E Mayne
Journal:  Ir J Med Sci       Date:  1986-12       Impact factor: 1.568

4.  Haemostatic measurements in childhood nephrotic syndrome.

Authors:  A T Elidrissy; M B Abdurrahman; H M Bahakim; M D Jones; A M Gader
Journal:  Eur J Pediatr       Date:  1991-03       Impact factor: 3.183

5.  Effect of corticosteroids on coagulation factors in children with nephrotic syndrome.

Authors:  N Ueda; S Kawaguchi; Y Niinomi; T Nonoda; J Matsumoto; M Ohnishi; T Yasaki
Journal:  Pediatr Nephrol       Date:  1987-07       Impact factor: 3.714

Review 6.  Platelet abnormalities in nephrotic syndrome.

Authors:  Benedicte Eneman; Elena Levtchenko; Bert van den Heuvel; Chris Van Geet; Kathleen Freson
Journal:  Pediatr Nephrol       Date:  2015-08-13       Impact factor: 3.714

7.  Platelet functions and coagulation changes in Indian children with nephrotic syndrome.

Authors:  Aliza Mittal; Kailash Chandra Aggarwal; Sumita Saluja; Archana Aggarwal; Binit Sureka
Journal:  J Clin Diagn Res       Date:  2013-08-01

Review 8.  Management of congenital nephrotic syndrome of the Finnish type.

Authors:  C Holmberg; M Antikainen; K Rönnholm; M Ala Houhala; H Jalanko
Journal:  Pediatr Nephrol       Date:  1995-02       Impact factor: 3.714

9.  Management of congenital nephrotic syndrome: consensus recommendations of the ERKNet-ESPN Working Group.

Authors:  Olivia Boyer; Franz Schaefer; Dieter Haffner; Detlef Bockenhauer; Tuula Hölttä; Sandra Bérody; Hazel Webb; Marie Heselden; Beata S Lipska-Ziętkiewicz; Fatih Ozaltin; Elena Levtchenko; Marina Vivarelli
Journal:  Nat Rev Nephrol       Date:  2021-01-29       Impact factor: 28.314

10.  Cerebral infarction in patient with minimal change nephrotic syndrome.

Authors:  A Babu; P Boddana; S Robson; L Ludeman
Journal:  Indian J Nephrol       Date:  2013-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.